Clinical Trials Logo

Filter by:
NCT ID: NCT04906720 Completed - Atrial Fibrillation Clinical Trials

Post-Ablation Pericarditis Reduction Study

PAPERS
Start date: May 20, 2021
Phase: Phase 2
Study type: Interventional

There has not been a prospective, randomized controlled trial of colchicine to reduce post-AF ablation pericarditis in an era of newer AF ablation techniques. The hypothesis is that an empiric pre and post AF ablation treatment protocol with colchicine may reduce the incidence and symptom severity of post-AF ablation related pericarditis. Thus, the goal of this study is to 1. Identify the incidence of post-AF ablation related pericarditis in patients undergoing ablation via high power, short duration strategy (shorter total RF time, but increased stability due to steerable catheters and possible difference from resistive vs conductive heating). 2. Identify potential differences in patients undergoing PVI only versus PVI + additional ablation 3. Identify whether patients on who are already on anti-inflammatories such as ASA or statins have a lower incidence than those without 4. Determine if an empiric treatment strategy with colchicine (for 7 days post ablation) reduces the incidence of post-operative AF

NCT ID: NCT04906707 Completed - Sickle Cell Disease Clinical Trials

Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease

Start date: October 27, 2021
Phase: N/A
Study type: Interventional

This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.

NCT ID: NCT04906694 Completed - Covid19 Clinical Trials

Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)

Start date: November 16, 2021
Phase: Phase 2
Study type: Interventional

This is a double-blind study designed to investigate the efficacy, safety and PK of a single dose of COVI-DROPS or matched placebo in outpatient adults who have tested positive for COVID-19 and are either asymptomatic or have mild symptoms.

NCT ID: NCT04906655 Completed - Skin Diseases Clinical Trials

An Open Label Study for Palmar Hyperhydrosis

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this open-label study is to evaluate the efficacy and safety of different methods of application of glycopyrronium cloth, 2.4% in patients with palmar hyperhidrosis

NCT ID: NCT04906590 Completed - Parkinson Disease Clinical Trials

PPMI Tau PET Imaging

Start date: August 30, 2021
Phase: Phase 2
Study type: Interventional

The Assessment of Brain Tau Burden in Participants with Parkinson's Disease in the PPMI Study (PPMI Tau PET Imaging) will evaluate if [18F] PI-2620 facilitates better understanding of Tau deposition in the brain in Parkinson's disease (PD).

NCT ID: NCT04906525 Completed - Clinical trials for Exercise Intervention

Resistance Training Effects on Gut Microbiome and Cardiometabolic Outcomes

Start date: May 19, 2021
Phase: N/A
Study type: Interventional

The overall objective of this study is to investigate the effects of resistance training on the gut microbiome and cardiometabolic outcomes in adults with overweight and obesity.

NCT ID: NCT04906499 Completed - Osteoarthritis Clinical Trials

Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Osteoarthritis (OA) is a leading cause of disability worldwide that affects millions of Americans each year. Posttraumatic OA (PTOA) significantly impacts patients after anterior cruciate ligament (ACL) injury and ACL reconstruction (ACLR) with approximately 50% of patients developing PTOA within 20 years of injury or surgery. Knee joint mechanical loading measured via physical activity (i.e. daily steps) is insufficient in individuals after ACLR compared to uninjured individuals. Establishing the beneficial effects of physical activity to promote optimal free-living knee joint mechanical loading and improve knee joint health will aid in the development of cost-effective interventions that prevent PTOA and health burden of the disease.

NCT ID: NCT04906421 Completed - Clinical trials for Nonalcoholic Fatty Liver Disease

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Start date: August 12, 2021
Phase: Phase 2
Study type: Interventional

This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy on TVB-2640 in subjects with non-alcoholic steatohepatitis (NASH). Subjects will be randomly assigned toTVB-2640 or matching placebo PO QD for 52 weeks, with the first dose administered on Day 1.

NCT ID: NCT04906148 Completed - Smoking Clinical Trials

Young Adults' Reactions to Low Nicotine Cigarette Advertising

YLA
Start date: May 27, 2021
Phase: N/A
Study type: Interventional

Reducing the nicotine content in combustible cigarettes to non-addictive levels has demonstrated promise as a safe and effective public health strategy for decreasing tobacco-caused morbidity and mortality. Little data are available, however, assessing how the marketing of low nicotine content (LNC) cigarettes could dampen their potential population health benefit. This study will examine LNC cigarette advertising content effects on message recall, viewing patterns, product perceptions, and use behaviors. Young adults (N = 340; 170 smokers, 170 non-smokers) will complete a single-session laboratory study using a 2 x 2 between-subject design to manipulate advertisement messaging accuracy (true vs. false/misleading) and content (implicit vs. explicit). Findings may be used to guide public health policy decisions related to regulating cigarette nicotine content and marketing.

NCT ID: NCT04906018 Completed - Clinical trials for Ultrasound Imaging of Anatomical Structures

A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0

Start date: May 16, 2021
Phase:
Study type: Observational

This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to evaluate the clinical performance of ScanNav Anatomy PNB when highlighting anatomical structures during UGRA scanning. Specifically, we aim to assess and quantify the correct/incorrect highlighting of anatomical structures associated with ScanNav Anatomy PNB during UGRA scanning.